Circulation Disorders News

Researcher Discovers Role of Gene Variant Associated With Alzheimer's Disease - HealthCanal.com



Researcher Discovers Role of Gene Variant Associated With Alzheimer's Disease 
HealthCanal.com
By Leslie Ridgeway - A gene variant responsible for vascular damage to the brain is a promising new target for drug therapy to fight Alzheimer's disease and other neurodegenerative diseases, according to research published on May 16 in Nature.

and more » 


Athersys Reports First Quarter 2012 Results - MarketWatch (press release)



Athersys Reports First Quarter 2012 Results 
MarketWatch (press release)
Raised $9.0 million in March 2012 through a private placement of common stock and warrants; -- Met with FDA to discuss advancing clinical development of MultiStem(R) for the prevention of graft-versus-host disease (GvHD), on basis of positive results ...

and more » 


Amicus Therapeutics Announces First Quarter 2012 Financial Results - MarketWatch (press release)



Amicus Therapeutics Announces First Quarter 2012 Financial Results 
MarketWatch (press release)
Final enrollment on track by YE12 -- Current enrollment in Phase 2 Study 013 for Fabry disease includes patients in higher dose group of migalastat HCl (450 mg) co-administered with Fabrazyme and in lower dose group of migalastat HCl (150 mg) ...

and more » 


BetterWayHealth.com Explores the Amazing Omega 3's! - Staugnews



BetterWayHealth.com Explores the Amazing Omega 3's! 
Staugnews
Some evidence even suggests that people with certain circulatory problems, such as varicose veins, benefit from Omega-3's, which may stimulate blood circulation and even reduce blood pressure. Just think! A product that may actually reduce the risk of ...

 


Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - EON: Enhanced Online News (press release)



Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... 
EON: Enhanced Online News (press release)
... the treatment of cardiac rhythm disorders. With 3750 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, ...

 


Do You Have Tapeworms In Your Brain? Maybe. - Jezebel



Do You Have Tapeworms In Your Brain? Maybe. 
Jezebel
Neurocysticercosis, as this disease is called, can also block the flow of cerebrospinal fluid, which puts pressure on the brain and can cause a coma or even death. The parasite can also cause seizures and violent convulsions of your muscles.

and more » 


Costs of screening children for sudden cardiac death outweigh its benefits - EurekAlert (press release)



Costs of screening children for sudden cardiac death outweigh its benefits 
EurekAlert (press release)
Boston, MA? An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, ...

and more » 


Health calendar - Montgomery Advertiser



Health calendar 
Montgomery Advertiser
Whether the wounds are the result of pressure, problems with circulation, or diseases such as diabetes, new treatments are available. Call 293-8138 for an appointment or for more information. Senior Advantage. Addressing the needs and concerns of ...

 


Why Alzheimer's disease scares us? (Part 3) - Arab News



Why Alzheimer's disease scares us? (Part 3) 
Arab News
COM I would like to return to our subject of Alzheimer disease where I left it three weeks ago on April 11. The condition is a cause of concern to many of us as we see first hand how it has escalated in the last several decades, ...

and more » 


Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - MarketWatch (press release)



Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... 
MarketWatch (press release)
... the treatment of cardiac rhythm disorders. With 3750 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, ...

and more »